FP7H2020HORIZON
Institut Catala de la Salut
- Country
- ESSpain
- Defence projects
- 0
- Projects, all programmes
- 47
- As coordinator
- 2
- EU contribution (CORDIS)
- EUR 13,910,429
- Active
- 2008 to 2025
Projects
47 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| SCOPEScreening for Chronic Kidney Disease (CKD) among Older People across Europe (SCOPE) | H2020 | 2015 | Participant | EUR 183,125 |
| COMBACTE-MAGNETCombatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections | FP7 | 2015 | Participant | EUR 162,589 |
| DISCHARGEDiagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies | FP7 | 2014 | Participant | EUR 147,340 |
| EUROFANCOLENPhase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action | FP7 | 2013 | Participant | EUR 268,368 |
| TRANSLINKDefining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves | FP7 | 2013 | Participant | EUR 588,620 |
| FLUTCOREDevelopment of a universal influenza vaccine based on tandem core technology | FP7 | 2013 | Participant | EUR 18,588 |
| BERENICEBenznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE | FP7 | 2012 | Coordinator | EUR 1,092,805 |
| DEVELAGEPathways common to brain development and ageing: defining strategies for preventive therapy and diagnostics | FP7 | 2012 | Participant | EUR 348,852 |
| EUROHYP-1European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke | FP7 | 2012 | Participant | Not stated |
| GAPVACGlioma Actively Personalized Vaccine Consortium | FP7 | 2012 | Participant | EUR 231,108 |
| BIO-DrIMPersonalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation | FP7 | 2012 | Participant | EUR 500,000 |
| EUROCONDOREuropean Consortium for the Early Treatment of Diabetic Retinopathy | FP7 | 2012 | Participant | EUR 330,602 |
| REINFORCEInflammatory Bowel Disease: an EU-NZ integrated approach for characterizing its molecular multifactorial mechanisms | FP7 | 2012 | Participant | EUR 69,300 |
| BAMIThe effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction | FP7 | 2011 | Participant | EUR 154,192 |
| ARTFORCEAdaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE | FP7 | 2011 | Participant | EUR 309,298 |
| ALICE RAPAddictions and Lifestyles In Contemporary Europe – Reframing Addictions Project | FP7 | 2011 | Participant | EUR 28,500 |
| IHMSInternational Human Microbiome Standards | FP7 | 2011 | Participant | EUR 99,964 |
| MABSOTDevelopment of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation | FP7 | 2010 | Participant | EUR 461,648 |
| CARE-MICARDIO REPAIR EUROPEAN MULTIDISCIPLINARY INITIATIVE | FP7 | 2010 | Participant | EUR 407,746 |
| SYSKIDSystems biology towards novel chronic kidney disease diagnosis and treatment | FP7 | 2010 | Participant | EUR 457,052 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.